|
1
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heger Z, Polanska H, Krizkova S, Balvan J,
Raudenska M, Dostalova S, Moulick A, Masarik M and Adam V:
Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted
oMWCNTs for synergistic in vitro anti-cancer effects in non-small
and small cell lung cancer. Colloids Surf B Biointerfaces.
150:131–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Richardson JS, Sethi G, Lee GS and Malek
SN: Chalepin: Isolated from Ruta angustifolia L. Pers
induces mitochondrial mediated apoptosis in lung carcinoma cells.
BMC Complement Altern Med. 16:3892016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tricker EM, Xu C, Uddin S, Capelletti M,
Ercan D, Ogino A, Pratilas CA, Rosen N, Gray NS, Wong KK and Jänne
PA: Combined EGFR/MEK inhibition prevents the emergence of
resistance in EGFR-mutant lung cancer. Cancer Discov. 5:960–971.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janne PA, Yang JC, Kim DW, Planchard D,
Ohe Y, Ramalingam SS, Ahn MJ, Kim SW, Su WC, Horn L, et al: AZD9291
in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J
Med. 372:1689–1699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Travis WD: Pathology of lung cancer. Clin
Chest Med. 32:669–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Panno ML, Giordano F, Rizza P, Pellegrino
M, Zito D, Giordano C, Mauro L, Catalano S, Aquila S, Sisci D, et
al: Bergapten induces ER depletion in breast cancer cells through
SMAD4-mediated ubiquitination. Breast Cancer Res Treat.
136:443–455. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xia W, Gooden D, Liu L, Zhao S, Soderblom
EJ, Toone EJ, Beyer WF Jr, Walder H and Spector NL: Photo-activated
psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2
signaling and triggering tumor cell apoptosis. PLoS One.
9:e889832014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Amicis F, Aquila S, Morelli C, Guido C,
Santoro M, Perrotta I, Mauro L, Giordano F, Nigro A, Andò S and
Panno ML: Bergapten drives autophagy through the up-regulation of
PTEN expression in breast cancer cells. Mol Cancer. 14:1302015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kroemer G, El-Deiry WS, Golstein P, Peter
ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni
W and Knight RA: Classification of cell death: Recommendations of
the Nomenclature Committee on Cell Death. Cell Death Differ. 12
Suppl 2:S1463–S1467. 2005. View Article : Google Scholar
|
|
11
|
Indran IR, Tufo G, Pervaiz S and Brenner
C: Recent advances in apoptosis, mitochondria and drug resistance
in cancer cells. Biochim Biophys Acta 1807. 735–745. 2011.
|
|
12
|
Li J and Yuan J: Caspases in apoptosis and
beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin CH, Lin HH, Kuo CY and Kao SH:
Aeroallergen Der p 2 promotes motility of human non-small cell lung
cancer cells via toll-like receptor-mediated up-regulation of
urokinase-type plasminogen activator and integrin/focal adhesion
kinase signaling. Oncotarget. 8:11316–11328. 2017.PubMed/NCBI
|
|
14
|
Hansen MB, Nielsen SE and Berg K:
Re-examination and further development of a precise and rapid dye
method for measuring cell growth/cell kill. J Immunol Methods.
119:203–210. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang WC, Tsai JJ, Kuo CY, Chen HM and Kao
SH: Non-proteolytic house dust mite allergen, Der p 2, upregulated
expression of tight junction molecule claudin-2 associated with
Akt/GSK-3β/β-catenin signaling pathway. J Cell Biochem.
112:1544–1551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CH, Hong YC and Kao SH: Aeroallergen
Der p 2 induces apoptosis of bronchial epithelial BEAS-2B cells via
activation of both intrinsic and extrinsic pathway. Cell Biosci.
5:712015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu JD, Wang YJ, Chen CH, Yu CF, Chen LC,
Lin JK, Liang YC, Lin SY and Ho YS: Molecular mechanisms of G0/G1
cell-cycle arrest and apoptosis induced by terfenadine in human
cancer cells. Mol Carcinog. 37:39–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keane TE, Petros JA, Velimirovich B, Yue
KT and Graham SD Jr: Methoxypsoralen phototherapy of transitional
cell carcinoma. Urology. 44:842–846. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu JZ, Situ ZQ, Wang W, Chen JY and Liu B:
Antitumor activity of psoralen on mucoepidermoid carcinoma cell
line MEC-1. Chin Med J (Engl). 105:913–917. 1992.PubMed/NCBI
|
|
20
|
Lee YM, Wu TH, Chen SF and Chung JG:
Effect of 5-methoxypsoralen (5-MOP) on cell apoptosis and cell
cycle in human hepatocellular carcinoma cell line. Toxicol In
Vitro. 17:279–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot
B, Hong WK and Lotan R: Implication of p53 in growth arrest and
apoptosis induced by the synthetic retinoid CD437 in human lung
cancer cells. Cancer Res. 59:2829–2833. 1999.PubMed/NCBI
|
|
22
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang D, Yue L, Yao R, Zhou L, Yang Y, Lu L
and Gao W: P53 prevent tumor invasion and metastasis by
down-regulating IDO in lung cancer. Oncotarget. 8:54548–54557.
2017.PubMed/NCBI
|
|
24
|
Alaee M, Nool K and Pasdar M: Plakoglobin
restores tumor suppressor activity of p53R175H mutant by
sequestering the oncogenic potential of β-catenin. Cancer Sci.
109:1876–1888. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu W, Cheng F, Yan W, Li X, Yao X, Song W,
Liu M, Shen X, Jiang H, Chen J, et al: Selective targeting
p53WT lung cancer cells harboring homozygous p53 Arg72
by an inhibitor of CypA. Oncogene. 36:4719–4731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Janssen A and Medema RH: Mitosis as an
anti-cancer target. Oncogene. 30:2799–2809. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abukhdeir AM and Park BH: p21 and p27:
Roles in carcinogenesis and drug resistance. Expert Rev Mol Med.
10:e192008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Valesky EM, Hrgovic I, Doll M, Wang XF,
Pinter A, Kleemann J, Kaufmann R, Kippenberger S and Meissner M:
Dimethylfumarate effectively inhibits lymphangiogenesis via p21
induction and G1 cell cycle arrest. Exp Dermatol. 25:200–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Wang H, Li M, Agrawal S, Chen X
and Zhang R: MDM2 is a negative regulator of p21WAF1/CIP1,
independent of p53. J Biol Chem. 279:16000–16006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hiyama H, Iavarone A, LaBaer J and Reeves
SA: Regulated ectopic expression of cyclin D1 induces
transcriptional activation of the cdk inhibitor p21 gene without
altering cell cycle progression. Oncogene. 14:2533–2542. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
LaBaer J, Garrett MD, Stevenson LF,
Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E: New
functional activities for the p21 family of CDK inhibitors. Genes
Dev. 11:847–862. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee HL, Lin CS, Kao SH and Chou MC: Gallic
acid induces G1 phase arrest and apoptosis of triple-negative
breast cancer cell MDA-MB-231 via p38 mitogen-activated protein
kinase/p21/p27 axis. Anticancer Drugs. 28:1150–1156. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen SY, Lin CH, Lin JT, Cheng YF, Chen HM
and Kao SH: Adenine causes cell cycle arrest and autophagy of
chronic myelogenous leukemia K562 cells via AMP-activated protein
kinase signaling. Oncol Lett. 14:5575–5580. 2017.PubMed/NCBI
|
|
34
|
Huang WS, Kuo HY, Kuo HC, Hsieh MC, Huang
CY, Lee KC, Lee KF, Shen CH, Tung SY and Teng CC: CIL-102-induced
cell cycle arrest and apoptosis in colorectal cancer cells via
upregulation of p21 and GADD45. PLoS One. 12:e01689892017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Evan GI, Brown L, Whyte M and Harrington
E: Apoptosis and the cell cycle. Curr Opin Cell Biol. 7:825–834.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gartel AL and Tyner AL: The role of the
cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer
Ther. 1:639–649. 2002.PubMed/NCBI
|
|
37
|
Kang KH, Kim WH and Choi KH: p21 promotes
ceramide-induced apoptosis and antagonizes the antideath effect of
Bcl-2 in human hepatocarcinoma cells. Exp Cell Res. 253:403–412.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Greco F and Vicent MJ: Combination
therapy: Opportunities and challenges for polymer-drug conjugates
as anticancer nanomedicines. Adv Drug Deliv Rev. 61:1203–1213.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Morth C and Valachis A: Single-agent
versus combination chemotherapy as first-line treatment for
patients with advanced non-small cell lung cancer and performance
status 2: A literature-based meta-analysis of randomized studies.
Lung Cancer. 84:209–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masters GA, Temin S, Azzoli CG, Giaccone
G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller
JH, et al: Systemic therapy for stage IV non-small-cell lung
cancer: American society of clinical oncology clinical practice
guideline update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI
|
